GCR Live: Antitrust in Life Sciences 2026
Freshfields is pleased to sponsor GCR Live: Antitrust in Life Sciences 2026, a leading forum focused on the competition, regulatory, and transactional issues shaping the pharmaceutical, biotech, and medical device sectors.
Partner Meghan Rissmiller will speak on the panel, "Dealmaking, pipelines, and regulatory risk – the current life sciences M&A landscape," exploring renewed deal activity, evolving merger scrutiny, and the antitrust considerations influencing strategic transactions across the life sciences industry.
